Milestone Scientific, Inc. (NYSE American: MLSS) has 344% upside potential before year-end 2023…!
These NYSE American listed medical device shares have soared more than 32% in the past 30 days on a breakout move with more than 780,000 shares trading recently…average 30-day daily volume is 146,000.
MLSS looks to be significantly undervalued and in the next several months could reach or even exceed Maxim Group’s 12-month price target of $4.00…click on this link to read their recent research report: Target Price $4.00 Maxim Research
Company Summary
Milestone Scientific is engaged in pioneering proprietary, technological systems, and solutions for the medical and dental markets. It develops, manufactures, markets and sells computer-controlled systems for the improved and painless delivery of local anesthetic.
Their proprietary DPS Dynamic Pressure Sensing Technology® instruments is the platform to advance the development of next-generation devices, regulating flow rate and monitoring pressure from the tip of the needle, through platform extensions of subcutaneous drug delivery, including local anesthetic. To learn more, view the MLSS brand video or visit milestonescientific.com.
MLSS Key Metrics @ 03/10/2023
| Closing Price | $0.90 (Up 32.4% in 30 days & 83.7% YTD) |
| 52 Week Range | $0.41 to $1.60 |
| Market Cap | $62,564,534 |
| Recent Volume | 781,000 shares |
| Shares Outstanding | 69,795,330 |
| Float | 50.62M |
| % Held by Insiders | 21.40% |
| % Held by Institutions | 7.24% |
| Shares Short (Feb 28, 2023) | 397.08k |
| Reporting Status | SEC Fully Reporting |
| Most Recent Filing: 10-Q for 09/30/2022 | Filed: 11/14/22 |
| Fiscal Year-end | 12/31 |
(Source: OTC Markets, Yahoo Finance, SEC filings)
Recent Company News:
Milestone Scientific Commences Sales of CompuFlo® Epidural Disposables within Three Prominent Colorado Pain Management Clinics
Milestone Scientific Granted U.S. Government’s System for Award Management (SAM) Registration of its CompuFlo® Epidural System
Milestone Scientific Announces 510(k) FDA Clearance for the Use of CompuFlo Epidural System in Thoracic Indications
Click on the above highlighted links to read the full press releases.
Bottom Line Observation
With rebounding revenues and a 3.95x current ratio, MLSS shares seem to be well positioned for a potential upward movement to $4.00 by year-end 2023 which could result in a 344% price gain for the speculative minded.
Interested investors, especially those focused on medical technology and healthcare, should consider adding Milestone Scientific to their radar screens or even start building a position in MLSS shares today.
__________________________________________________________________________
Disclaimer and Disclosures: MicroCap MarketPlace (MCMP) is a financial publisher and not a FINRA broker/dealer or investment adviser. MCMP is not registered with the SEC / U.S. Securities and Exchange Commission or any state securities regulatory agency. Readers, subscribers and web site visitors are responsible for individual investment decisions. All information contained in our newsletters or on our web site and in our blogs should be independently verified with the featured companies and readers should always conduct their own research and due diligence and engage professional investment advisers as they deem appropriate before making investment decisions. Please review the Terms and Conditions of Use, including without limitation all disclaimers of warranties and limitations on liability contained therein. Your use of any information on our websites, contained herein or in our newsletters and blogs constitutes your agreement of same. MCMP did not receive any compensation for this article, nor does it hold a position in any shares. We believe the information contained herein and, in our publications, to be reliable but cannot guarantee its accuracy; therefore, all information is provided as is without warranty of any kind. Past results are not necessarily indicative of future performance.
POSTED BY:
Research and Editorial Staff
MicroCapMarketPlace.com
© 2023 MicroCapMarketPlace, All Rights Reserved
MicroCapMarketPlace.com wishes to thank the PennyStockNews Team for bringing Milestone Scientific to our attention.
